Previous 10 | Next 10 |
2023-10-22 08:13:00 ET Exxon Mobil: Superior Asset Base And Execution To Generate Returns Throughout The Cycle Ford Motor: The Quiet Before The Storm Why I'm Adding To My Coca-Cola Position General Motors makes new 'comprehensive' offer to UAW Apple, Goog...
2023-10-20 17:46:51 ET More on Regeneron Pharmaceuticals, Sanofi Sanofi Q3 2023 Earnings Preview: Expect Positive Results, But No Share Price Spike Sanofi: 3 Reasons For A Buy Regeneron Pharmaceuticals: Game-Changing Discoveries In Healthcare GoodRx to offer ...
2023-10-20 06:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-10-19 14:15:01 ET Summary Sanofi is set to announce Q3 2023 earnings next Friday, Oct. 27. The company has forecast mid single-digit growth in EPS for 2023, with an estimated currency impact of -6.5% to -7.5%. Sanofi's key asset, Dupixent, continues to perform well and is...
2023-10-19 09:58:30 ET More on Sanofi, GoodRx, etc. GoodRx Faces Challenges In Subscription Plans, But Its Valuation Already Prices This In GoodRx Stock: Earnings Momentum Keeps It Interesting Sanofi: 3 Reasons For A Buy Sanofi presents encouraging data on at...
Sanofi hosted the founding ceremony of the homeless futsal club ‘Dream’ and organized a friendly match as a part of the Helping Hands program Sanofi employees and ‘Dream’ members interacted through the friendly match Sanofi has carried out social respon...
2023-10-16 16:46:31 ET Summary Closed-end funds are often more sensitive to market movements, through being leveraged but also their discount/premium mechanics. Eaton Vance Tax-Advantaged Global Dividend Income Fund has seen a drop due to September's weakness and also a widening d...
2023-10-15 07:15:00 ET Summary Suzhou MediLink Therapeutics out-licenses global rights for its HER3 antibody-drug conjugate candidate to BioNTech in a $1.1 billion deal. Beijing AI drug discovery company BioMap forms a strategic collaboration with Sanofi to co-develop new protein ...
2023-10-13 17:26:22 ET More on Sanofi Sanofi: 3 Reasons For A Buy Sanofi: A 'Buy' Recommendation For Undervalued Growth Potential Sanofi (SNY) Q2 2023 Earnings Call Transcript Mirati Therapeutics soars on report of Sanofi takeover interest Teva, Sanof...
2023-10-13 15:47:48 ET Intercept Pharmaceuticals, which agreed to be sold to Sanofi ( NASDAQ: SNY ) late last month, quickly dropped 3% amid a new report from the European Medicines Agency. The study failed to show that Ocaliva was more effective than placebo (a dummy trea...
News, Short Squeeze, Breakout and More Instantly...
Sanofi ships U.S. influenza vaccines for the 2024/25 season PR Newswire Customers will start receiving shipments from July 10 with additional shipments through October to healthcare provider offices, pharmacies and other immunizers to support fall immunization campaigns. ...
2024-07-09 06:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...